1. Integrated Analysis of Microarray and RNA-Seq Data for the Identification of Hub Genes and Networks Involved in the Pancreatic Cancer
- Author
-
Sabaoon Zeb, Mehak Rafiq, Maryum Nisar, Zamir Hussain, Iqra Arshad, Rehan Zafar Paracha, Rumeza Hanif, and Sidra Adil
- Subjects
0301 basic medicine ,Microarray ,pancreatic cancer ,Context (language use) ,RNA-Seq ,Computational biology ,QH426-470 ,enrichment analysis ,differential expression ,03 medical and health sciences ,0302 clinical medicine ,Gene expression ,medicine ,Genetics ,Paca ,Gene ,Genetics (clinical) ,Original Research ,co-expression network ,biology ,Wnt signaling pathway ,Cancer ,therapeutic target ,TCGA ,medicine.disease ,biology.organism_classification ,030104 developmental biology ,focal adhesion pathway ,030220 oncology & carcinogenesis ,Molecular Medicine ,biomarker - Abstract
Pancreatic cancer (PaCa) is the seventh most fatal malignancy, with more than 90% mortality rate within the first year of diagnosis. Its treatment can be improved the identification of specific therapeutic targets and their relevant pathways. Therefore, the objective of this study is to identify cancer specific biomarkers, therapeutic targets, and their associated pathways involved in the PaCa progression. RNA-seq and microarray datasets were obtained from public repositories such as the European Bioinformatics Institute (EBI) and Gene Expression Omnibus (GEO) databases. Differential gene expression (DE) analysis of data was performed to identify significant differentially expressed genes (DEGs) in PaCa cells in comparison to the normal cells. Gene co-expression network analysis was performed to identify the modules co-expressed genes, which are strongly associated with PaCa and as well as the identification of hub genes in the modules. The key underlaying pathways were obtained from the enrichment analysis of hub genes and studied in the context of PaCa progression. The significant pathways, hub genes, and their expression profile were validated against The Cancer Genome Atlas (TCGA) data, and key biomarkers and therapeutic targets with hub genes were determined. Important hub genes identified included ITGA1, ITGA2, ITGB1, ITGB3, MET, LAMB1, VEGFA, PTK2, and TGFβ1. Enrichment analysis characterizes the involvement of hub genes in multiple pathways. Important ones that are determined are ECM–receptor interaction and focal adhesion pathways. The interaction of overexpressed surface proteins of these pathways with extracellular molecules initiates multiple signaling cascades including stress fiber and lamellipodia formation, PI3K-Akt, MAPK, JAK/STAT, and Wnt signaling pathways. Identified biomarkers may have a strong influence on the PaCa early stage development and progression. Further, analysis of these pathways and hub genes can help in the identification of putative therapeutic targets and development of effective therapies for PaCa.
- Published
- 2021
- Full Text
- View/download PDF